drug development

Tech And Materials Science Come To The Fore At Singapore’s 2023 President’s Science And Technology Awards

Two of Singapore’s top scientists and three rising stars were honored at the 2023 President’s Science and Technology Award Ceremony for their scientific, technological and economic contributions to Singapore.

Professor Cheong Sok Ching smiling directly at the camera. The Head of Research in the Head and Neck Cancer division of Cancer Research Malaysia, Cheong wants to show Malaysian scientists abroad that it is possible to conduct impactful research that benefits the public back in their homeland.

Asia’s Rising Scientist: Cheong Sok Ching

Professor Cheong Sok Ching is championing the battle against cancers that disproportionately affect Asians, and leading drug development research in Malaysia.

A Clean Slate: Revolutionizing Pharmaceutical Cleaning

Working hand in hand with industry partners, researchers from the Singapore Institute of Technology (SIT) are finding innovative ways to streamline cleaning in pharmaceutical manufacturing.

Ensuring Quality, Straight From The Lab Bench

Sartorius’ suite of solutions helps pharmaceutical companies maintain quality across all steps of the drug development and manufacturing workflow—ensuring patient safety in the process.

Asia’s Big Biomedical Bet Pays Off

From performing outsourced research and manufacturing generics, Asia's biomedical researchers are now among the world's most innovative.

Dealing Coronavirus A Knockout Punch

As the COVID-19 pandemic continues to rage around the world, old therapeutics are being given a second chance to fight a new foe. Here are seven of them.

WuXi STA Opens Nucleic Acid Drug Manufacturing Facility

Nucleic acid drugs have the potential to treat neuromuscular and metabolic diseases where small molecule drugs have failed.

Advancing Antibody Research

Powerful antibody engineering technologies and a culture of collaboration set Chugai Pharmabody Research apart, says CEO Dr. Tomoyuki Igawa.

Boehringer Ingelheim And Enleofen Bio Strike Billion-Dollar Deal

Enleofen Bio will receive more than US$1 billion in earnout payments from Boehringer Ingelheim’s acquisition of worldwide exclusive rights to its preclinical interleukin-11 platform.

WuXi AppTec And BioSolveIT Set Up Molecule Library

The GalaXi® platform grants researchers access to billions of virtual molecules, paving the way for faster drug discovery and development.